Search the web
Welcome, Guest
[Sign Out, My Account]
 EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI 		Symbol Lookup | Financial Search
ACUR > SEC Filings for ACUR > Form 8-K on 10-Dec-2012All Recent SEC Filings

Show all filings for ACURA PHARMACEUTICALS, INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for ACURA PHARMACEUTICALS, INC

10-Dec-2012

Other Events


Item 8.01 Other Events

On December 10, 2012 we issued a press release announcing the launch of NexafedŽ
[pseudoephedrine hydrochloride (HCl)], a 30 mg immediate-release pseudoephedrine product, combining effective nasal-congestion relief with a unique technology that disrupts the conversion of pseudoephedrine into the dangerous drug, methamphetamine A copy of our press release is attached as Exhibit 99.1 hereto and is incorporated by reference herein.

  Add ACUR to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ACUR - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.